COMPANY PROFILE / #2675
Evidium
San Francisco, CAVenture Capital-Backed
OVERVIEW
Developer of a clinical intelligence platform designed to make medical knowledge computational and transparent for data-driven healthcare. The company offers precision tools that integrate clinical and financial data to connect care and coverage, enabling healthcare providers and payors to predict patient trajectories and costs, improve clinical outcomes, and support informed decision-making.
已融资33.21
最新估值52.70
员工数31
成立年份2020
公司概况
- Companies
- Evidium
- Description
- Developer of a clinical intelligence platform designed to make medical knowledge computational and transparent for data-driven healthcare. The company offers precision tools that integrate clinical and financial data to connect care and coverage, enabling healthcare providers and payors to predict patient trajectories and costs, improve clinical outcomes, and support informed decision-making.
- Website
- www.evidium.com
- HQ Location
- San Francisco, CA
- Year Founded
- 2020
- Keywords
- ai medical platform, augmented intelligence software, clinical decision support, data-centric platform, healthcare business, medical advancement
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 33.21
- First Financing Date
- 22-Apr-2021
- First Financing Size
- 1.03
- First Financing Valuation
- —
- Last Financing Date
- 07-Nov-2025
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 22.00
- Last Financing Valuation
- 52.70
- Last Financing Status
- Completed
- Last Known Valuation
- 52.70
- Last Known Valuation Date
- 07-Nov-2025
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 85.08
- Valuation Estimate Growth Rate
- 61.45%
- Active Investors
- Hammer Ventures, Health2047, IKJ Capital, Innovaccer, Interwoven Ventures, Mindset Ventures, Perplexity, Punja Global Ventures, Sage Hill Investors, SeedFolio, United Healthcare Services, WGG Partners, World Within Ventures
- # Active Investors
- 13
- Acquirers
- —
团队与联系人
- Employees
- 31
- Employee Growth %
- 3.33%
- Employee History
- 2026: 31, 2025: 30, 2024: 17, 2023: 14, 2022: 12, 2021: 10
- Primary Contact
- John Harland
- Primary Contact Title
- VP Finance & Operations
- Primary Contact Email
- john.harland@evidium.com
- Primary Contact Phone
- —
增长与经营
- Revenue
- 0.03
- Revenue Growth %
- 65.00%
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 3.46x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 76
- Majestic Referring Domains
- 90
- SimilarWeb Unique Visitors
- 465
- SimilarWeb Unique Visitors Change
- 96
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 4%
- Success Probability Over Time – 3 Year
- 15%
- Success Probability Over Time – 5 Year
- 26%
记录来源：public.companies · 原始序号 #2675 · 所有字段均按数据库原值展示。